Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Midday movers: Palantir and Spotify surge, and more

Published 02/06/2024, 09:00 AM
Updated 02/06/2024, 11:13 AM
© Reuters

(Updated - February 6, 2024 11:10 AM EST)

Investing.com -- Main U.S. indexes were mixed Tuesday as investors waded through a deluge of corporate earnings reports amid lingering doubts about the timing of Fed rate cuts following recent comments from officials.

Here are some of the biggest U.S. stock movers today:

Eli Lilly (NYSE:LLY) erased a pre-market gain of 5% despite forecasting 2024 sales that topped estimated thanks in large part to soaring expected demand for its weekly diabetes injection. Shares were slightly lower midday, but still up since Monday.

Shares in NXP Semiconductors (NASDAQ:NXPI) rose 1%in after the automotive chipmaker reported fourth-quarter results that beat Wall Street estimates and current-quarter income guidance that was in-line with expectations.

Spotify (NYSE:SPOT) shares rose 7% after the music streaming giant posted a first-quarter monthly active users outlook that was stronger than anticipated.

U.S.-listed Chinese stocks, including Alibaba (NYSE:BABA) and NetEase (NASDAQ:NTES), rose after the China Securities Regulatory Commission rolled out new support measures for the domestic stock market. The regulator vowed to guide more local funds and asset managers to buy into the Chinese market, and said it would instruct local firms to repurchase more shares.

Palantir (NYSE:PLTR) shares surged 25% after the software and analysis firm unveiled a better-than-projected annual profit forecast.

Chegg (NYSE:CHGG) shares fell 1% after the online educational services provider's first-quarter adjusted core earnings outlook missed estimates.

United Parcel Service (NYSE:UPS) shares rose 4% after analysts at UBS lifted their recommendation for the courier to buy from neutral.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Symbotic (SYM) declined 23% after forecasting a sharp decline in EBITDA in the second quarter. Analysts expressed hope that the warehouse automation technology company's profitability guidance was conservative.

GE HealthCare (NASDAQ:GEHC) climbed 10.6% after it topped EPS and revenue estimates. Management said it was confident heading into 2024 amid the backdrop of an improved capital equipment landscape.

Willis Towers Watson (NASDAQ:WTW) climbed 5% after it posted strong earnings in the fourth quarter due to strong organic growth and margins. It also maintained its full year outlook.


Additional reporting by Louis Juricic

Latest comments

"Beat" the criminally rigged, low-ball "estimate" continues.  Of course none of this is "priced in" to the most grossly overvalued market in history.
the predictable paid ignorant complaints from Mitch right on schedule .
Go argue w/ me ish on how the US market is worse the the CCP one.
ah the good ol' free market - China "instructing" and "guiding" folk to invest in the Chinse stock market - OR ELSE join the Uihghers in the re-education camps. mind you, not much better in the US with back door liquidity and share buy back schemes keeping the US top five tech just about going higher
you figured that out. So, buy It!!!!!!!! Cmon. What's the problem? Or you believe what you said I jump in. Or neither you believe. Live by your words.
"not much better in the US"  --  Then go long CCP and short  the US markets.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.